These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 32132005)

  • 21. [Metformin is also recommended in mild and moderate renal failure].
    Zechmann S
    Praxis (Bern 1994); 2015 Mar; 104(7):370-1. PubMed ID: 25804780
    [No Abstract]   [Full Text] [Related]  

  • 22. The Association between Metformin Therapy and Lactic Acidosis.
    Kuan IHS; Savage RL; Duffull SB; Walker RJ; Wright DFB
    Drug Saf; 2019 Dec; 42(12):1449-1469. PubMed ID: 31372935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lactic acidosis incidence with metformin in patients with type 2 diabetes and chronic kidney disease: A retrospective nested case-control study.
    Alvarez CA; Halm EA; Pugh MJV; McGuire DK; Hennessy S; Miller RT; Lingvay I; Vouri SM; Zullo AR; Yang H; Chansard M; Mortensen EM
    Endocrinol Diabetes Metab; 2021 Jan; 4(1):e00170. PubMed ID: 33532612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse event notifications implicating metformin with lactic acidosis in Australia.
    Huang W; Castelino RL; Peterson GM
    J Diabetes Complications; 2015; 29(8):1261-5. PubMed ID: 26104729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism and application of metformin in kidney diseases: An update.
    Song A; Zhang C; Meng X
    Biomed Pharmacother; 2021 Jun; 138():111454. PubMed ID: 33714781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limitations of metformin use in patients with kidney disease: are they warranted?
    Vasisht KP; Chen SC; Peng Y; Bakris GL
    Diabetes Obes Metab; 2010 Dec; 12(12):1079-83. PubMed ID: 20977579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin use in decompensated heart failure.
    Boyd A; Nawarskas J
    Cardiol Rev; 2008; 16(5):269-72. PubMed ID: 18708828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study.
    Eppenga WL; Lalmohamed A; Geerts AF; Derijks HJ; Wensing M; Egberts A; De Smet PA; de Vries F
    Diabetes Care; 2014 Aug; 37(8):2218-24. PubMed ID: 24842984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.
    Solini A; Penno G; Bonora E; Fondelli C; Orsi E; Trevisan R; Vedovato M; Cavalot F; Cignarelli M; Morano S; Ferrannini E; Pugliese G;
    J Am Geriatr Soc; 2013 Aug; 61(8):1253-61. PubMed ID: 23889588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements.
    van Berlo-van de Laar IR; Vermeij CG; Doorenbos CJ
    J Clin Pharm Ther; 2011 Jun; 36(3):376-82. PubMed ID: 21545617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin in peritoneal dialysis: a pilot experience.
    Al-Hwiesh AK; Abdul-Rahman IS; El-Deen MA; Larbi E; Divino-Filho JC; Al-Mohanna FA; Gupta KL
    Perit Dial Int; 2014 Jun; 34(4):368-75. PubMed ID: 24584596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chronic kidney diseases, metformin and lactic acidosis].
    Borbély Z
    Vnitr Lek; 2016 Apr; 62(4):299-303. PubMed ID: 27250607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risks of Metformin in Type 2 Diabetes and Chronic Kidney Disease: Lessons Learned from Taiwanese Data.
    Rhee CM; Kovesdy CP; Kalantar-Zadeh K
    Nephron; 2017; 135(2):147-153. PubMed ID: 27760420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin associated lactic acidosis (MALA): clinical profiling and management.
    Moioli A; Maresca B; Manzione A; Napoletano AM; Coclite D; Pirozzi N; Punzo G; Menè P
    J Nephrol; 2016 Dec; 29(6):783-789. PubMed ID: 26800971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin OK in CKD?
    Drug Ther Bull; 2014 Apr; 52(4):37. PubMed ID: 24698854
    [No Abstract]   [Full Text] [Related]  

  • 36. Metformin-associated lactic acidosis in a peritoneal dialysis patient.
    Almaleki N; Ashraf M; Hussein MM; Mohiuddin SA
    Saudi J Kidney Dis Transpl; 2015 Mar; 26(2):325-8. PubMed ID: 25758883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin and lactic acidosis in an Australian community setting: the Fremantle Diabetes Study.
    Kamber N; Davis WA; Bruce DG; Davis TM
    Med J Aust; 2008 Apr; 188(8):446-9. PubMed ID: 18429709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter S; Greyber E; Pasternak G; Salpeter E
    Cochrane Database Syst Rev; 2003; (2):CD002967. PubMed ID: 12804446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
    Salpeter S; Greyber E; Pasternak G; Salpeter E
    Cochrane Database Syst Rev; 2002; (2):CD002967. PubMed ID: 12076461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidiabetic medication use in patients with type 2 diabetes and chronic kidney disease.
    Rhee JJ; Han J; Montez-Rath ME; Kim SH; Cullen MR; Stafford RS; Winkelmayer WC; Chertow GM
    J Diabetes Complications; 2019 Nov; 33(11):107423. PubMed ID: 31537413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.